Late Breaking Abstract Submission
The Scientific Committee invites the submission of Late Breaking Abstracts reporting high impact, novel data that were not available at the time of the regular abstract deadline.
Late Breaking Abstracts should present scientifically significant findings, such as final results from practice changing research for example. Submissions will undergo a rigorous peer review process, and only a limited number will be accepted. Submission deadline: 10 May 2026
The presentation of innovative oncology pharmacy research is the cornerstone of the ECOP 7 Conference, offering the opportunity to share important findings, showcase recent advances and updates in oncology pharmacy practice and to encourage collaboration and information sharing within the profession.
Abstract Regulations
With the submission of an abstract to ECOP 7, the first author (presenting author):
- Accepts responsibility for the accuracy of the submitted abstract.
- Confirms that all authors are aware of and agree to the content of the abstract and support the data presented.
- Identifies any financial interest in products or processes described in the abstract. This information is to be forwarded to the Scientific Committee together with the abstract.
- States that, for studies involving human or animal subjects, permission has been obtained from the relevant regulatory authority and properly informed consent given where appropriate.
- Identifies, obtains and discloses any financial interest in products or processes described in the abstract for all abstract authors. This includes stock ownership, membership of an advisory board or board of directors, corporate-sponsored research and other substantive relationships.
- Releases the copyright on behalf of all authors to ESOP and gives permission for the abstract, when selected for presentation, to be published in an issue of the European Journal of Oncology Pharmacy, as well as on the ECOP 7 website. The copyright of the abstract remains with the author(s).
Submitted abstracts cannot be withdrawn after 27 March 2026.
Abstract Format and Content
In order to be considered, an abstract should respect the following guidelines:
- The abstract must be submitted in good English. The Scientific Committee reserves the right to reject those abstracts, which are presented in poor English, or may request an immediate revision by the presenter.
- Abstract titles should be brief and should reflect the content of the abstract.
- Commercial names may not be used in the abstract title.
- No more than 10 authors can be listed. Please write down the authors names like this (first name last name): “John Doe”. Only institutional affiliations, cities and countries should follow.
- An abstract is not an activity report. If you want to highlight the implementation of a new activity, you need to specify evaluation criteria.
- Abstracts should be organised under the headings:
- Introduction Background : Briefly explain the scientific question, the gap in knowledge, or the rationale for your study. Objective(s) : State clearly what you aimed to investigate or demonstrate.
- Material and method: Summarize the study design, sample/data, experimental approaches
- Results and discussion: Present the most important findings, with quantitative elements. Report scientific, or practical relevance of your findings. Briefly outline the study’s limitations
- Conclusion: Highlight the scientific implications, what the findings mean, and why they matter. Are the findings applicable to another hospital? Suggest logical next steps
- Only one data table is permitted in the body of the abstract. Illustrations and figures are not allowed and will be deleted if submitted.
- Abbreviations may be used if standard or if spelled out and defined at the first use. Compounds should be mentioned with the generic name, in lower cases. Commercial names are admitted in the text, with an ®, and if in brackets following the generic name, i.e. “generic (Commercial ®)”.
- Supplementary data or appendices will not be accepted.
- Figures or photographs are not allowed. Symbols and structures of drugs are allowed and should be drawn in black.
Only the submitting author will receive confirmation of receipt by e-mail from the ECOP 7 Conference Secretariat within 5 days of submission. This confirmation of abstract receipt is NOT a notice of acceptance.
For questions regarding the online submission process please contact: Lena Schlömer (abstracts@ecop.events)
For any « scientific question » please contact Dr Christophe Bardin (christophe.bardin@aphp.fr)
Abstract Selection Process
The Scientific Committee will make the selection of abstracts for oral, poster spotlight or poster presentations from Saturday, 28th February 2026. End of March 2026/beginning of April, the first author (presenter) will receive an e-mail with the result of the review and the Scientific Committee’s decision on the submitted abstract.
If a selected author cannot attend, the presenting author should assign a replacement. Possibility of replacement is by Monday, 1st June 2026.
The following presentation formats are applicable for ECOP 7:
- Oral Communications: the abstract is selected for oral communications in a main program symposium. The time of Oral Communication presentations will be published to a later point in time.
- Poster in the Spotlight: abstracts that have been selected for presentation in a Poster Spotlight Session. The time of Poster Spotlight will be published to a later point of time.
- Poster: abstracts that have been selected for poster presentation are grouped by topic and will be displayed in the Poster Session area at the conference venue. (digital posters screens)
Please note that if the abstract is accepted for oral or poster presentation, the abstract and poster will only be published on the ECOP website if one of the authors is a registered participant and full payment has been received by the advised deadline.
Abstract Submission procedure
Abstracts must be submitted online, until 22nd March 2026.
- When finished with the online submission, please click the “SEND” button for the final submission of the abstract. As confirmation of your submission, a message will appear on the screen informing that the abstract has been successfully submitted to our database.
- If you have not sent your abstract by the deadline of 22nd March 2026 your abstract cannot be accepted.
- Within 5 days of submission, only the presenting author will receive confirmation by e-mail. This confirmation of abstract submission does not mean your abstract has been selected for presentation.
- If you do not receive any confirmation, please contact Lena Schlömer (abstracts@ecop.events) within one week following the submission of the abstract.
- Submitting an abstract for ECOP 7 does not constitute registration for the conference. Abstract presenters must register to attend ECOP 7 by following the instructions for registration on the website.
Only abstracts submitted online can be accepted. Abstracts submitted on paper or by e-mail attachment will not be considered.
Poster Session
Poster presenters have to send their digital poster via email to the conference secretariat (abstract@ecop.events). The deadline for submission of the poster (PDF-file) will be 28th May 2026. Only submitted posters can candidate for the best poster award.
The dimensions of your printed poster must not exceed 95 cm (width) and 230 cm (height). We recommend to use the ECOP pptx template and print the standard size of A0.
Presenting authors are kindly requested to be present close to their poster for poster explanations during coffee breaks.
The abstracts and the number for the posters in the program will be published on this website on 30th May 2026 at the latest. After the congress all submitted posters will be published on this website.
Dr Christophe Bardin, ECOP 7 Scientific Coordinator abstracts
Prof Dr Robert Terkola, ECOP 7 Chair Scientific Committee